Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
about
MAHILA: a protocol for evaluating a nurse-delivered mHealth intervention for women with HIV and psychosocial risk factors in IndiaVaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocolMaternal post-absorptive leucine kinetics during late pregnancy in US women with HIV taking antiretroviral therapy: a cross-sectional pilot study.Preterm Birth and Low Birth Weight after In Utero Exposure to Antiretrovirals Initiated during Pregnancy in Yaoundé, CameroonOption B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in BrazilSexual Practices, Fertility Intentions, and Awareness to Prevent Mother-to-Child Transmission of HIV Among Infected Pregnant Women at the Yaounde Central Hospital.Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.Antiretroviral therapy and preterm birth in HIV-infected women.Pregnancy Outcomes in HIV-Infected Women: Experience from a Tertiary Care Center in IndiaPregnancy incidence and intention after HIV diagnosis among women living with HIV in Canada.PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.Neonatal and Infant Mortality Risk Associated with Preterm and Small for Gestational Age Births in Tanzania: Individual Level Pooled Analysis Using the Intergrowth Standard.Intestinal barrier dysfunction and microbial translocation in HIV-infected pregnant women is associated with preterm birth.
P2860
Q28598268-ACF7A5AF-0F8A-4D1D-AAF9-837EECA237DCQ33916922-9C963564-015E-4CD4-A0CD-FF1A9155A729Q35927192-1BE8E38C-6D7D-4FD7-9772-5589E443B82DQ35964999-4599D03C-43A9-4042-A29E-9E96521F7D41Q36300046-77859504-BF5F-4532-BAAB-7AFBA706E2A3Q36443769-8DF4C4AF-4EA5-4429-B077-C5B8FD99DFC8Q37218117-E007D44A-81B3-4A55-9831-CC120BF4342CQ37298218-0E4E2A66-9235-43D1-8369-B9689B42E65AQ38185748-14F2119C-CC46-415E-93C5-53AB5C918495Q38629430-9B02B1CF-1172-4A0A-AC51-945ECF183B0CQ38670050-E3B5AF58-0A6B-4B53-A574-3A92A19422D7Q40440550-9833ED42-08E6-4DC2-8B7E-F92CE276398EQ46300796-0F41AE8A-43AB-40B8-A3EA-97EB040D5008Q54246777-5C06AC18-2B3E-457B-946E-399FDC4A6C5F
P2860
Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effect of highly active antire ...... MTCT program in western India.
@en
Effect of highly active antiretroviral treatment
@nl
type
label
Effect of highly active antire ...... MTCT program in western India.
@en
Effect of highly active antiretroviral treatment
@nl
prefLabel
Effect of highly active antire ...... MTCT program in western India.
@en
Effect of highly active antiretroviral treatment
@nl
P2093
P356
P1476
Effect of highly active antire ...... MTCT program in western India.
@en
P2093
Inge Hutter
Ritu Parchure
Sanjeevani Kulkarni
Shrinivas Darak
Trupti Darak
Vinay Kulkarni
P304
P356
10.1089/APC.2012.0401
P577
2013-03-01T00:00:00Z